These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34719556)

  • 1. Constructing a developmental and reproductive toxicity database of chemicals (DART NIHS DB) for integrated approaches to testing and assessment.
    Yamada T; Miura M; Kawamura T; Ushida K; Inoue K; Kuwagata M; Katsutani N; Hirose A
    J Toxicol Sci; 2021; 46(11):531-538. PubMed ID: 34719556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COSMOS next generation - A public knowledge base leveraging chemical and biological data to support the regulatory assessment of chemicals.
    Yang C; Cronin MTD; Arvidson KB; Bienfait B; Enoch SJ; Heldreth B; Hobocienski B; Muldoon-Jacobs K; Lan Y; Madden JC; Magdziarz T; Marusczyk J; Mostrag A; Nelms M; Neagu D; Przybylak K; Rathman JF; Park J; Richarz AN; Richard AM; Ribeiro JV; Sacher O; Schwab C; Vitcheva V; Volarath P; Worth AP
    Comput Toxicol; 2021 Aug; 19():100175. PubMed ID: 34405124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A strategy for safety assessment of chemicals with data gaps for developmental and/or reproductive toxicity.
    Blackburn K; Daston G; Fisher J; Lester C; Naciff JM; Rufer ES; Stuard SB; Woeller K
    Regul Toxicol Pharmacol; 2015 Jul; 72(2):202-15. PubMed ID: 25910676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value and limitation of structure-based profilers to characterize developmental and reproductive toxicity potential.
    Manganelli S; Schilter B; Scholz G; Benfenati E; Lo Piparo E
    Arch Toxicol; 2020 Mar; 94(3):939-954. PubMed ID: 32100055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of OECD screening tests 421 (reproduction/developmental toxicity screening test) and 422 (combined repeated dose toxicity study with the reproduction/developmental toxicity screening test).
    Reuter U; Heinrich-Hirsch B; Hellwig J; Holzum B; Welsch F
    Regul Toxicol Pharmacol; 2003 Aug; 38(1):17-26. PubMed ID: 12878050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FutureTox IV Workshop Summary: Predictive Toxicology for Healthy Children.
    Knudsen TB; Fitzpatrick SC; De Abrew KN; Birnbaum LS; Chappelle A; Daston GP; Dolinoy DC; Elder A; Euling S; Faustman EM; Fedinick KP; Franzosa JA; Haggard DE; Haws L; Kleinstreuer NC; Buck Louis GM; Mendrick DL; Rudel R; Saili KS; Schug TT; Tanguay RL; Turley AE; Wetmore BA; White KW; Zurlinden TJ
    Toxicol Sci; 2021 Apr; 180(2):198-211. PubMed ID: 33555348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural features of endocrine active chemicals--A comparison of in vivo and in vitro data.
    Lewin G; Escher SE; van der Burg B; Simetska N; Mangelsdorf I
    Reprod Toxicol; 2015 Aug; 55():81-94. PubMed ID: 25461902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative prediction of repeat dose toxicity values using GenRA.
    Helman G; Patlewicz G; Shah I
    Regul Toxicol Pharmacol; 2019 Dec; 109():104480. PubMed ID: 31550520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in using the ToxRefDB as a resource for toxicity prediction modeling.
    Plunkett LM; Kaplan AM; Becker RA
    Regul Toxicol Pharmacol; 2015 Aug; 72(3):610-4. PubMed ID: 26003516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Framework for identifying chemicals with structural features associated with the potential to act as developmental or reproductive toxicants.
    Wu S; Fisher J; Naciff J; Laufersweiler M; Lester C; Daston G; Blackburn K
    Chem Res Toxicol; 2013 Dec; 26(12):1840-61. PubMed ID: 24206190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of different generations and developmental stages in studies on reproductive toxicity.
    Schulz F; Batke M; Mangelsdorf I; Pohlenz-Michel C; Simetska N; Lewin G
    Toxicol Lett; 2014 Apr; 226(2):245-55. PubMed ID: 24525464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AOP-DB: A database resource for the exploration of Adverse Outcome Pathways through integrated association networks.
    Pittman ME; Edwards SW; Ives C; Mortensen HM
    Toxicol Appl Pharmacol; 2018 Mar; 343():71-83. PubMed ID: 29454060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The era of 3Rs implementation in developmental and reproductive toxicity (DART) testing: Current overview and future perspectives.
    Beekhuijzen M
    Reprod Toxicol; 2017 Sep; 72():86-96. PubMed ID: 28552675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches and considerations for the assessment of immunotoxicity for environmental chemicals: a workshop summary.
    Boverhof DR; Ladics G; Luebke B; Botham J; Corsini E; Evans E; Germolec D; Holsapple M; Loveless SE; Lu H; van der Laan JW; White KL; Yang Y
    Regul Toxicol Pharmacol; 2014 Feb; 68(1):96-107. PubMed ID: 24280359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond AOPs: A Mechanistic Evaluation of NAMs in DART Testing.
    Rajagopal R; Baltazar MT; Carmichael PL; Dent MP; Head J; Li H; Muller I; Reynolds J; Sadh K; Simpson W; Spriggs S; White A; Kukic P
    Front Toxicol; 2022; 4():838466. PubMed ID: 35295212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical testing strategies for predicting health hazards to children.
    Lamb JC; Brown SM
    Reprod Toxicol; 2000; 14(2):83-94. PubMed ID: 10825671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adverse outcome pathway concept: A basis for developing regulatory decision-making tools.
    Delrue N; Sachana M; Sakuratani Y; Gourmelon A; Leinala E; Diderich R
    Altern Lab Anim; 2016 Oct; 44(5):417-429. PubMed ID: 27805824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure assessments in reproductive and developmental toxicity testing: An IQ-DruSafe industry survey on current practices and experiences in support of exposure-based high dose selection.
    Andrews PA; McNerney ME; DeGeorge JJ
    Regul Toxicol Pharmacol; 2019 Oct; 107():104413. PubMed ID: 31229519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of effect levels of chemicals from quantitative structure-activity relationship (QSAR) models. I. Chronic lowest-observed-adverse-effect level (LOAEL).
    Mumtaz MM; Knauf LA; Reisman DJ; Peirano WB; DeRosa CT; Gombar VK; Enslein K; Carter JR; Blake BW; Huque KI
    Toxicol Lett; 1995 Sep; 79(1-3):131-43. PubMed ID: 7570650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.